全球颅内支架市场：市场规模（依适应症、产品类型、最终用户和地区划分）、未来预测

颅内支架的市场规模及预测

2024 年颅内支架市场规模为 4.3717 亿美元，预计到 2032 年将达到 8.4896 亿美元，2026 年至 2032 年的复合年增长率为 8.65%。

颅内支架是一种小型管状医疗设备，植入脑血管后可治疗各种脑血管疾病，特别适用于血流不规则或动脉狭窄的疾病。这些支架通常由生物相容性材料製成，例如镍钛合金或钴铬合金，并可自膨胀或球囊扩张。支架用于为薄弱或狭窄的动脉提供结构支撑，保持其畅通，并确保充足的血流流向脑部各个区域。这项技术对于预防中风、修復动脉瘤以及治疗脑动脉硬化等疾病至关重要。

颅内支架用于治疗多种疾病。在治疗脑动脉瘤时，支架用于维持血管壁并防止破裂。它们也用于治疗缺血性中风，尤其是在需要进行机械血栓切除术以去除血栓的情况下。此外，颅内支架在治疗脑动脉狭窄方面发挥着至关重要的作用，它可以扩张狭窄的动脉并恢復正常的血流。这些支架与血管造影术等最新的影像技术结合使用，以确保精确放置并有效恢復血管的完整性。

材料科学、影像技术和微创手术的进步。创新可能集中于开发具有更高生物相容性和药物释放型能力的支架，以降低血管再阻塞和血栓症的风险。此外，将智慧技术融入支架，例如即时监测血流和血管状态的感测器，可以透过提供持续数据并实现脑血管疾病的预防性管理，从而改变患者照护。随着研究的进展，脑支架的应用预计将会扩展，为患有各种神经血管疾病的患者提供更好的治疗效果，并将其应用扩展到新的治疗领域。

全球颅内支架市场动态

影响全球颅内支架市场的关键市场动态是：

主要市场驱动因素：

脑血管疾病发生率上升：中风和动脉粥状硬化等脑血管疾病发生率的上升推动了颅内支架市场的发展。随着世界人口老化，这些疾病的盛行率不断上升，需要颅内支架置入术等现代医疗技术来妥善管理和治疗。这一趋势在人口老化的富裕国家尤其普遍，这导致对有效脑血管治疗的需求迅速增加。

医学影像技术的进步：高解析度磁振造影（MRI）和CT血管造影术等医疗图像技术彻底改变了脑血管疾病的识别和治疗。影像技术的进步使得颅内支架的放置更加精准，从而提高了其疗效和安全性。这项技术进步使临床医生能够更好地观察和导航复杂的脑动脉，从而促进颅内支架置入治疗，降低手术风险，并改善患者预后。

支架设计创新：支架设计的新进展，例如药物释放型和生物可吸收支架的出现，正在推动颅内支架市场的发展。这些发展旨在提高支架疗效，降低血管再阻塞风险，并改善患者的长期预后。生物相容性和柔韧性更高的新材料和新设计的出现，正在推动颅内支架的应用，使治疗更加成功，并扩大患者群体。

政府的支持性倡议和政策：这些旨在改善医疗保健效果的政策正在推动颅内支架市场的成长。资助研发、补贴创新医疗设备以及改善公共医疗体系的计画都促进了颅内支架的使用率的提升。这些政策不仅有助于扩大市场，也使更多人能够获得尖端的神经血管治疗。

主要挑战

患者选择的复杂性：选择合适的颅内置入术患者需要考虑多个方面，包括病变形态、血管解剖和合併症。患者选择标准的复杂性可能会限制颅内支架的广泛应用，并且需要进行广泛的考虑以优化治疗结果。

技能和训练要求：介入神经放射学需要丰富的专业知识和训练才能实施颅内支架置入置入术，包括先进的影像技术和导管介入手术。技术人员的短缺可能会阻碍该技术的广泛应用和品质保证。

新兴替代疗法和技术：血流转向器和外科手术等替代疗法的进步对颅内支架置入术术构成了竞争威胁。为了在不断变化的神经血管内治疗环境中保持商业性可行性，支架技术必须不断创新并具有适应性。

併发症和不利事件风险：颅内置入术的相关风险包括血栓症、出血和血管穿孔，这些风险可能导致严重的神经系统后果。管理这些风险需要经验丰富的医生和专业的医疗设施，确保在不同患者群体中一致的安全性和有效性也极具挑战性。

主要趋势：

药物释放型技术的整合：药物释放型颅内支架的开发旨在透过将治疗药物直接释放到治疗部位来减少血管再阻塞，从而可能提高裸金属支架的长期疗效。

新兴市场和可及的医疗保健：新兴经济体不断增长的医疗保健基础设施和不断增加的可支配收入正在推动颅内支架的采用，从而改善获得最新脑血管治疗的机会。

监管发展和标准化：简化监管管道和製定颅内支架使用一致建议的努力将透过确保设备在製造和临床环境中的安全性、有效性和品质来促进市场发展。

个人化医疗方法：基因分析和生物标记发现的进步正在开闢个人化治疗选择，利用颅内支架根据个别患者特征和疾病状况进行客製化。

目录

第一章全球颅内支架市场介绍

• 市场概览
• 分析范围
• 先决条件

第二章执行摘要

第三章 已验证的市场研究分析方法

• 资料探勘
• 验证
• 第一手资料
• 资料来源列表

4. 全球颅内支架市场展望

• 概述
• 市场动态
  • 驱动程式
  • 限制因素
  • 机会
• 波特五力模型
• 价值链分析

5. 全球颅内支架市场（按适应症）

• 概述
• 脑动脉瘤
• 颅内狭窄

6. 全球颅内支架市场（依产品类型）

• 概述
• 支架辅助弹簧圈栓塞术
• 球囊扩张型支架
• 自动扩张型支架

7. 全球颅内支架市场（依最终用户）

• 概述
• 医院
• 门诊手术中心
• 其他的

8. 全球颅内支架市场（按地区）

• 概述
• 北美洲
  • 美国
  • 加拿大
  • 墨西哥
• 欧洲
  • 德国
  • 英国
  • 法国
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 其他亚太地区
• 世界其他地区
  • 拉丁美洲
  • 中东

9. 全球颅内支架市场竞争格局

• 概述
• 各公司市场排名
• 主要发展策略

第十章 公司简介

• Boston Scientific Corporation
• DePuy Synthes
• Medtronic
• Terumo Corporation
• Phenox
• Acandis
• Stryker Corporation
• Cook Medical
• MicroPort Scientific

第十一章 附录

• 相关分析

Intracranial Stents Market Size And Forecast

Intracranial Stents Market size was valued at USD 437.17 Million in 2024 and is projected to reach USD 848.96 Million by 2032, growing at a CAGR of 8.65% from 2026 to 2032.

Intracranial stents are small, tube-like medical devices that are implanted within the brain's blood vessels to treat a variety of cerebrovascular disorders, particularly those characterized by irregular blood flow or narrowed arteries. These stents are often made of biocompatible materials like nitinol or cobalt-chromium alloy and can either self-expand or expand with a balloon. They are utilized to offer structural support to less effective or restricted arteries, keeping them open and allowing enough blood flow to brain areas. This technique is critical for preventing strokes, repairing aneurysms, and managing diseases like cerebral atherosclerosis.

Intracranial stents are used to treat a variety of medical disorders. The treatment of cerebral aneurysms is when stents are used to maintain the vascular wall and prevent rupture. They are also used to manage ischemic stroke, particularly when mechanical thrombectomy is required to remove a blood clot. Furthermore, intracranial stents play an important role in the treatment of cerebral artery stenosis by widening limited arteries and restoring normal blood flow. These stents are used with modern imaging techniques, such as angiography, to ensure exact placement and effectiveness in restoring vascular integrity.

Advancements in material science, imaging technologies, and minimally invasive surgery. Innovations are likely to focus on developing stents with improved biocompatibility and drug-eluting capabilities to lower the risk of restenosis and thrombosis. Furthermore, incorporating smart technology into stents, such as sensors for real-time monitoring of blood flow and vessel status, has the potential to transform patient care by giving continuous data and allowing for proactive management of cerebrovascular illnesses. As research advances, the use of cerebral stents is projected to grow, providing better outcomes for patients with a broader spectrum of neurovascular disorders and potentially expanding their usage to new therapeutic areas.

Global Intracranial Stents Market Dynamics

The key market dynamics that are shaping the global intracranial stents market include:

Key Market Drivers:

Rising Incidence of Cerebrovascular Diseases: The increasing incidence of cerebrovascular diseases, including stroke and atherosclerosis, is driving the intracranial stents market. As the world's population ages, the prevalence of these disorders increases, need modern medical techniques such as intracranial stenting to properly manage and treat them. This tendency is especially evident in affluent countries with aging populations, where the demand for effective cerebrovascular treatments is quickly increasing.

Advancements in Medical Imaging Technology: Medical imaging technology, such as high-resolution MRI and CT angiography, has transformed the identification and treatment of cerebrovascular diseases. Enhanced imaging enables more precise implantation of intracranial stents, improving their efficacy and safety. This technological advancement has facilitated the use of intracranial stenting treatments because clinicians can now better observe and navigate intricate cerebral arteries, lowering procedural risks and increasing patient outcomes.

Technological Innovations in Stent Design: New developments in stent design, such as the emergence of drug-eluting and bioresorbable stents, are moving the intracranial stents market ahead. These developments seek to improve stent efficacy, lower the risk of restenosis, and improve long-term patient outcomes. The arrival of new materials and designs with improved biocompatibility and flexibility has boosted the use of intracranial stents, making treatments more successful and expanding the patient pool.

Supportive Government Initiatives and Policies: These policies aimed at improving healthcare outcomes are driving growth in the intracranial stents market. Programs that fund research and development, give subsidies for innovative medical devices, and improve public healthcare systems all contribute to the rising use of intracranial stents. These policies not only promote market expansion but also ensure that a larger portion of the public has access to cutting-edge cerebrovascular treatments.

Key Challenges:

Complexity of Patient Selection: To select appropriate candidates for intracranial stenting, several aspects must be considered, including lesion morphology, vascular anatomy, and comorbidities. The difficulty of patient selection criteria can limit the broad use of intracranial stents, necessitating extensive review to optimize treatment outcomes.

Skill and Training Requirements: Neurointerventionalists must have different expertise and training to perform intracranial stenting, which includes advanced imaging techniques and catheter-based treatments. The scarcity of skilled personnel can impede widespread adoption and quality assurance.

Emerging Alternatives and Technologies: Advancements in alternative therapies, such as flow diverters and surgical procedures, pose competitive threats to intracranial stenting. To remain commercially relevant in the ever-changing landscape of cerebrovascular therapies, stent technology must be constantly innovated and adaptable.

Risk of Complications and Adverse Events: Risks associated with intracranial stenting procedures include thrombosis, bleeding, and blood vessel perforation which can cause severe neurological consequences. Managing these risks necessitates the use of highly skilled practitioners and specialized facilities, making it difficult to ensure consistent safety and efficacy across diverse patient populations.

Key Trends:

Integration of Drug-Eluting Technologies: The development of drug-eluting intracranial stents intends to reduce restenosis by releasing therapeutic drugs directly at the treatment site, with the potential for improved long-term efficacy over bare-metal stents.

Emerging Markets and Accessible Healthcare: Growing healthcare infrastructure and rising disposable budgets in emerging nations are encouraging increased adoption of intracranial stents, hence improving access to modern cerebrovascular treatments.

Regulatory Advancements and Standardization: Efforts to streamline regulatory channels and develop consistent recommendations for intracranial stent use drive market growth by guaranteeing device safety, efficacy, and quality in both production and clinical practice.

Personalized Medicine Approaches: Advances in genetic profiling and biomarker discovery are opening the way for individualized treatment options with intracranial stents that are matched to individual patient characteristics and illness profiles.

Global Intracranial Stents Market Regional Analysis

Here is a more detailed regional analysis of the global intracranial stents market:

North America:

North America dominates the global intracranial stents market, thanks to its strong healthcare infrastructure and broad use of new medical technology. The region benefits from a mature ecosystem of healthcare providers and research institutes that specialize in neurovascular treatments.

Major intracranial stent manufacturers are located or have large operations in North America, which promotes innovation and ensures access to cutting-edge therapies. The high frequency of cerebrovascular illnesses and neurological disorders, combined with robust regulatory frameworks that support medical device approvals, reinforces North America's dominance in the intracranial stents industry.

According to the Medicare Coverage Database, the intracranial arteries contribute to 8-10% of all ischemic strokes in the United States (Thijs et al., 2000). Intracranial artery stenosis is responsible for around 70,000 to 90,000 strokes or transient ischemic episodes (TIAs) per year (Chimowitz et al., 2005). The major intracranial arteries are the anterior and middle cerebral arteries, the basilar artery, and the vertebral artery's intracranial parts.

Asia Pacific:

The Asia Pacific region's intracranial stents market is expected to grow rapidly due to a combination of demographic and economic factors. A growing population with higher healthcare requirements, combined with rising occurrences of cerebrovascular illnesses and neurological problems, drives demand for improved neuro interventional treatments such as intracranial stenting. Furthermore, there is a growing awareness of preventive healthcare practices, which promote early detection and intervention, increasing the region's use of intracranial stents.

The growing middle class in Asia Pacific countries contributes significantly to market growth. With more disposable income, this demographic group desires access to modern medical technologies and procedures, such as intracranial stenting.

Increasing expenditures in healthcare infrastructure and the construction of specialist neurology clinics are improving access to neuro interventional operations, meeting Asia Pacific's growing demand for effective cerebrovascular therapies. These factors highlight the region's emergence as a key growth hub in the intracranial stents market.

Global Intracranial Stents Market: Segmentation Analysis

The Global Intracranial Stents Market is Segmented on the basis of Disease Indication, Product Type, End-User, And Geography.

Intracranial Stents Market, By Disease Indication

• Brain Aneurysm
• Intracranial Stenosis

Based on Disease Indication, the market is fragmented into Brain Aneurysm and Intracranial Stenosis. In the Intracranial Stents market, Intracranial Stenosis is expected to be the fastest-expanding category. This is being driven by the increasing prevalence of cerebrovascular disorders, which are a key risk factor for stenosis. Increased awareness and developments in diagnostic tools are allowing for earlier detection of stenosis, necessitating the insertion of stents to prevent stroke. Brain aneurysms are anticipated to have the largest share due to proven treatment approaches including stents, although stenosis is growing at a quicker rate due to an expanding pool of patients requiring this treatment.

Intracranial Stents Market, By Product Type

• Stent-Assisted Coil Embolization
• Balloon Expanding Stents
• Self-Expanding Stents

Based on Product Type, the market is segmented into Stent-Assisted Coil Embolization, Balloon Expanding Stents, and Self-Expanding Stents.

• Self-expanding stents are likely to take over due to their ease of use and adaptability to a variety of vessel geometries. However, balloon-expanding stents are predicted to be the most rapidly developing category. This is because they provide accurate positioning and improved control during deployment, which is increasingly important for complex processes.

Intracranial Stents Market, By End-User

• Hospitals
• Ambulatory Surgical Centers

Based on End-Users, the market is segmented into Hospitals and Ambulatory Surgical Centers. Hospitals are now the dominant segment in the intracranial stents market, owing to their well-equipped facilities and specialist surgeons for difficult intracranial stent surgeries. However, ambulatory surgery facilities are likely to be the most rapidly developing segment. Advances in minimally invasive stent installation techniques, combined with rising costs, have made these facilities a more cost-effective choice for certain procedures.

Intracranial Stents Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the World
• On the basis of Geography, the Global Intracranial Stents Market is classified into North America, Europe, Asia Pacific, and the Rest of the World. North America is expected to be the dominating area in the intracranial stents market. This is due to a mix of variables, including high healthcare costs, established infrastructure, and a big patient population with cerebrovascular illnesses. Asia Pacific is likely to experience the most rapid expansion. Rising disposable incomes, more understanding of stroke prevention, and an aging population making these conditions more likely all contribute to this trend.

Key Players

The "Global Intracranial Stents Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are Boston Scientific Corporation, DePuy Synthes, Penumbra, Inc., Medtronic, Terumo Corporation, Phenox, Acandis, Stryker Corporation, Cook Medical, and MicroPort Scientific. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

• Intracranial Stents Market Recent Developments
• In September 2022, Phenox GmbH launched the pEGASUS HPC stent globally at the ESMINT 2022 congress in Nice, France. The pEGASUS HPC stent is the first stent of its kind to introduce coating technology for the treatment of ICAD and aneurysms.
• In June 2022, India Medtronic Private Limited, a wholly-owned subsidiary of Medtronic plc, announced a CE- certified fourth-generation flow diverter, PipelineTM Vantage with Shield Technology for endovascular treatment of brain aneurysms

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL INTRACRANIAL STENTS MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL INTRACRANIAL STENTS MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis

5 GLOBAL INTRACRANIAL STENTS MARKET, BY DISEASE INDICATION

• 5.1 Overview
• 5.2 Brain Aneurysm
• 5.3 Intracranial Stenosis

6 GLOBAL INTRACRANIAL STENTS MARKET, BY PRODUCT TYPE

• 6.1 Overview
• 6.2 Stent-Assisted Coil Embolization
• 6.3 Balloon Expanding Stents
• 6.4 Self-Expanding Stents

7 GLOBAL INTRACRANIAL STENTS MARKET, BY END USER

• 7.1 Overview
• 7.2 Hospitals
• 7.3 Ambulatory Surgical Centers
• 7.4 Others

8 GLOBAL INTRACRANIAL STENTS MARKET, BY GEOGRAPHY

• 8.1 Overview
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
  • 8.2.3 Mexico
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 U.K.
  • 8.3.3 France
  • 8.3.4 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Rest of Asia Pacific
• 8.5 Rest of the World
  • 8.5.1 Latin America
  • 8.5.2 Middle East

9 GLOBAL INTRACRANIAL STENTS MARKET COMPETITIVE LANDSCAPE

• 9.1 Overview
• 9.2 Company Market Ranking
• 9.3 Key Development Strategies

10 COMPANY PROFILES

• 10.1 Boston Scientific Corporation
  • 10.1.1 Overview
  • 10.1.2 Financial Performance
  • 10.1.3 Product Outlook
  • 10.1.4 Key Developments
• 10.2 DePuy Synthes
  • 10.2.1 Overview
  • 10.2.2 Financial Performance
  • 10.2.3 Product Outlook
  • 10.2.4 Key Developments
• 10.3 Medtronic
  • 10.3.1 Overview
  • 10.3.2 Financial Performance
  • 10.3.3 Product Outlook
  • 10.3.4 Key Developments
• 10.4 Terumo Corporation
  • 10.4.1 Overview
  • 10.4.2 Financial Performance
  • 10.4.3 Product Outlook
  • 10.4.4 Key Developments
• 10.5 Phenox
  • 10.5.1 Overview
  • 10.5.2 Financial Performance
  • 10.5.3 Product Outlook
  • 10.5.4 Key Developments
• 10.6 Acandis
  • 10.6.1 Overview
  • 10.6.2 Financial Performance
  • 10.6.3 Product Outlook
  • 10.6.4 Key Developments
• 10.7 Stryker Corporation
  • 10.7.1 Overview
  • 10.7.2 Financial Performance
  • 10.7.3 Product Outlook
  • 10.7.4 Key Developments
• 10.8 Cook Medical
  • 10.8.1 Overview
  • 10.8.2 Financial Performance
  • 10.8.3 Product Outlook
  • 10.8.4 Key Developments
• 10.9 MicroPort Scientific
  • 10.9.1 Overview
  • 10.9.2 Financial Performance
  • 10.9.3 Product Outlook
  • 10.9.4 Key Developments

11 Appendix

• 11.1 Related Research